Medicamen Biotech Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Oct 2026
As of Oct 2026, promoters hold 42.57% of Medicamen Biotech, FIIs hold 4.35%, DIIs hold 0.00% and the public holds 53.01%. Promoter holding rose by 2.11 percentage points from Sep 2026.
Get an alert when Medicamen Biotech reports results or its shareholding changes. Free account.
Promoters
42.57%
+2.11 pp QoQ
FIIs
4.35%
−0.14 pp QoQ
DIIs
0.00%
unchanged QoQ
Public
53.01%
−1.99 pp QoQ
Medicamen Biotech shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Government | Public | Shareholders |
|---|---|---|---|---|---|---|
| Oct 2026 | 42.57% | 4.35% | 0.00% | 0.05% | 53.01% | 11,662 |
| Sep 2026 | 40.46% | 4.49% | 0.00% | 0.05% | 55.00% | 11,680 |
| Jun 2026 | 40.46% | 0.07% | 0.40% | 0.05% | 59.01% | 11,047 |
| Mar 2026 | 40.46% | 0.10% | 0.00% | 0.05% | 59.39% | 10,806 |
| Dec 2025 | 40.46% | 0.02% | 0.44% | 0.05% | 59.02% | 10,967 |
| Sep 2025 | 40.46% | 0.05% | 0.59% | 0.05% | 58.84% | 11,177 |
| Jun 2025 | 40.46% | 0.00% | 0.64% | 0.05% | 58.83% | 10,808 |
| Mar 2025 | 43.16% | 0.12% | 0.69% | 0.06% | 55.99% | 10,435 |
| Dec 2024 | 42.99% | 0.06% | 0.87% | 0.06% | 56.04% | 10,576 |
| Sep 2024 | 42.99% | 0.06% | 1.17% | 0.00% | 55.79% | 10,792 |
| Jun 2024 | 42.99% | 0.06% | 1.17% | 0.00% | 55.78% | 10,652 |
| Mar 2024 | 43.21% | 0.12% | 0.99% | 0.00% | 55.69% | 10,639 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Government · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹397 cr, the promoter group's 42.57% stake is worth ₹169 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Medicamen Biotech shareholding: common questions
What is the promoter holding in Medicamen Biotech?
Promoters hold 42.57% of Medicamen Biotech as of Oct 2026. Their stake rose by 2.11 percentage points from Sep 2026.
How much do FIIs hold in Medicamen Biotech?
Foreign institutional investors (FIIs) held 4.35% of Medicamen Biotech in Oct 2026, −0.14 pp versus Sep 2026.
How much do mutual funds and other DIIs hold in Medicamen Biotech?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 0.00% of Medicamen Biotech in Oct 2026, unchanged versus Sep 2026.
Is the promoter holding in Medicamen Biotech pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Medicamen Biotech.
How has Medicamen Biotech's promoter holding changed in the last year?
Promoter holding moved from 40.46% in Dec 2025 to 42.57% in Oct 2026 (+2.11 pp).
How many shareholders does Medicamen Biotech have?
Medicamen Biotech had 11,662 shareholders in Oct 2026, compared with 11,680 in Sep 2026.